This registry is collecting information on people with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called METex14 skipping alterations. You could join if you have this type of cancer, have signed a consent form, and are starting or already receiving systemic therapy (treatment that affects the whole body). The registry aims to understand how treatments are changing and how well they work over time. Researchers will look at how your tumor responds to treatment (Best Overall Response and Tumor Response according to RECIST 1.1 criteria) and how long people live (Overall Survival) for up to about 4.9 years. This is an observational study, meaning you will receive your usual care, and no specific treatments are being tested.

Study design

This is an observational study collecting data from up to 700 participants. It is a disease registry, meaning it gathers information on a specific patient group over time without testing new treatments.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your health information will be collected for up to approximately 4.9 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.